Ellis Bio is a startup. Ellis Bio has been acquired. Brouky records 1 investor associated with the company.
Develops epigenomic tools intended for use by clinicians and researchers to analyze and interpret epigenomic information.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.